| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |